ORIONPHARM

Orion Pharma Ltd. · Pharmaceuticals and Chemicals · Cat Z

0/100

High risk

৳30.1

Score breakdown

Technical read

RSI (14)64.4

MACDbullish

Bollingerinside bands (+1.4σ)

Price cycle (Wyckoff)MARKUP

Health trenddeteriorating

Flow pressureaccumulation

Valuation

Fair value ()

Upside—

Dividend yield+3.30%

Fundamental verdictAT-RISK

Confidence—

Levels

Resistance

৳30.4

৳31.5

৳32.6

৳34.2

Support

৳30

৳28.5

৳27.6

৳26.6

Historical bounce zones

Oct 28, 2024: ৳30.9→৳47.5 +54%

Feb 5, 2025: ৳28.5→৳33.5 +18%

Jun 1, 2025: ৳25.5→৳30.4 +19%

Jun 22, 2025: ৳27.5→৳34.9 +27%

Aug 12, 2025: ৳29.9→৳42.9 +43%

Nov 16, 2025: ৳22.9→৳30.8 +34%

Jan 28, 2026: ৳26.4→৳32.6 +23%

May 19, 2026: ৳25.1→৳29.4 +17%

Historical outlook

Based on how similar setups behaved historically — not a prediction of what will happen.

10-day 40% vs 40% market avg Typical move: -4.7% / -0.8% / 3.9%

30-day 31% vs 42% market avg Typical move: -8.1% / -1.2% / 7.1%

Signals: Evening Star

Reference levels

Descriptive reference points from the analysis — not instructions to buy or sell.

Entry readAVOID (dormant/dirty)

Reference stopn/a

Reference target—

Timing notestay out

strong artificial activity (score 263); speculative profile — not core-quality. Phase: DORMANT (2% >200-MA, flow ACC) -> watch. Z-cat. ⚠ SOLVENCY DISTRESS (Altman Z 2.14, DETERIORATING) — bankruptcy risk. high-risk. [fundamentals AT-RISK (dividend cut risk), yield 3.3%]